MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-02-0020478
Clinsync Clinical Research Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹15.75 Cr
▼ 38% YoY
Net loss · FY 2025
₹4.37 Cr
Net margin -27.8%
EBITDA · FY 2025
-₹1.81 Cr
EBITDA margin -11.5%
Authorised capital
₹6 Cr
Registered with MCA
Paid-up capital
₹4.39 Cr
Issued & subscribed
Open charges
₹2.26 Cr
Satisfied ₹4.56 Cr
Company age
15 yrs
Est. 2011
Employees · EPFO
147
Provident fund records
About Clinsync Clinical Research Private Limited
Data last updated:
Clinsync Clinical Research Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 21 March 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U73200TG2011PTC073413. Its GSTIN is 36AAECC3366N1ZB (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹6 Cr and a paid-up capital of ₹4.39 Cr. It is led by directors including Sandhya Nandiraju (Whole-Time Director) and Suresh Kumar Nandiraju.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Jsr Mall Plot No. 7 To 18 Madinaguda Village Serilingampally Mandal, Hyderabad, Telangana, India – 500050.
As per the financials filed for FY 2025, the company reported a revenue of ₹15.75 Cr, a decline of 38% compared to the previous year. For the same year it recorded a net loss of ₹4.37 Cr (net margin -27.8%) and EBITDA of -₹1.81 Cr (EBITDA margin -11.5%). Revenue has declined at a compounded annual rate (CAGR) of 21% over three years and 2% over five years.
The company has about 147 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: ClinSync CR. As per MCA filings, the company has open charges of ₹2.26 Cr and satisfied charges of ₹4.56 Cr on record. Court records list 1 case involving the company, including 1 filed by the company.
Clinsync Clinical Research Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0020478). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website clinsynccro.com.
Company details
CIN U73200TG2011PTC073413
Registration Number 073413
Incorporation Date 21 March 2011
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-02-0020478
CIN history
Clinsync Clinical Research has one previous CIN (Corporate Identification Number): U73200AP2011PTC073413. The current CIN is U73200TG2011PTC073413, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U73200TG2011PTC073413 | Current |
| U73200AP2011PTC073413 | Previous |
Key People
Sandhya Nandiraju Whole-Time Director Suresh Kumar Nandiraju Director Attili Venkata Satya Suresh Director Recognitions & Rankings of Clinsync Clinical Research
Contact details
Clinsync Clinical Research Private Limited's registered office is in Hyderabad, Telangana. Its website is clinsynccro.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressJsr Mall Plot No. 7 To 18 Madinaguda Village Serilingampally Mandal, Hyderabad, Telangana, India – 500050
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Clinsync Clinical Research Private Limited, buy the company report.
Comprehensive company report
Clinsync Clinical Research Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Clinsync Clinical Research operates one associated brand: ClinSync CR. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers clinical trials, BA/BE studies, and data management for biotech industries. | clinsynccro.com |
Business activity
The main business activity of Clinsync Clinical Research is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Clinsync Clinical Research Private Limited, buy the company report.
Financials of Clinsync Clinical Research Private Limited
FY 2024 filings availableClinsync Clinical Research Private Limited reported revenue of ₹15.75 Cr (down 38% YoY) for FY 2025.
Revenue · FY 2025
₹15.75 Cr ▼ 38%
Net loss · FY 2025
₹4.37 Cr margin -27.8%
EBITDA · FY 2025
-₹1.81 Cr margin -11.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 38%
3 years · compounded
▼ 21%
5 years · compounded
▼ 2%
EBITDA CAGR growth
1 year
▼ 183%
3 years · compounded
▼ 33%
5 years · compounded
▼ 20%
Revenue has declined at a compounded annual rate (CAGR) of 2% over five years, including a 38% fall in the latest year. EBITDA fell 183% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.81 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹4.37 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -11.5% | ||||
| Net Profit Margin | -27.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Clinsync Clinical Research Private Limited, buy the company report.
Board of directors of Clinsync Clinical Research Private Limited
Clinsync Clinical Research has 4 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suresh Kumar Nandiraju Also directs: Osr Projects LLP, Pharmarics Private Limited, Vidur Human Care Private Limited and 3 more | Director | 26 Aug 2024 | 2 Years 2 Months | Current |
| Attili Venkata Satya Suresh Also directs: Addsus Solutions and Services LLP, Mcube Health Sciences Private Limited, Schedulemymedicines Private Limited and 5 more | Director | 30 Nov 2020 | 5 Years 10 Months | Current |
| Koteswara Prasad Sripathipanditaradhyula Also directs: Ramkosun Infra Solutions Private Limited | Director | 30 Nov 2020 | 5 Years 10 Months | Current |
| Sandhya Nandiraju | Whole-Time Director | 08 Jan 2018 | 8 Years 9 Months | Current |
Peer comparison
Clinsync Clinical Research Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Finoso Pharma Private Limited | ₹17.69 Cr (FY 2025) | -7.0% | Hyderabad, Telangana, India | |||
| Semler Research Center Private Limited | ₹17.66 Cr (FY 2025) | 926.0% | Bengaluru, Karnataka, India | |||
| Suven Life Sciences Limited | ₹17.55 Cr (FY 2025) | -47.0% | Hyderabad, Telangana, India | |||
| Sravathi Advance Process Technologies Private Limited | ₹17.29 Cr (FY 2025) | 40.0% | Bangalore, Karnataka, India | |||
| Clinsync Clinical Research Private Limitedthis company | ₹15.75 Cr (FY 2025) | -₹4.37 Cr | -27.8% | -38.0% | 147 | Hyderabad, Telangana, India |
| Eurofins Advinus Discovery Services Private Limited | ₹15.34 Cr (FY 2025) | -3.0% | Bengaluru, Karnataka, India | |||
| Clinwave Research Private Limited | ₹14.89 Cr (FY 2025) | -13.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Clinsync Clinical Research Private Limited, buy the company report.
Auditor
Clinsync Clinical Research Private Limited is audited by S. SURYA PRAKASA RAO & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S. SURYA PRAKASA RAO & CO. | FY 2023 | 004296S |
Shareholding
The shareholding of Clinsync Clinical Research Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Clinsync Clinical Research Private Limited, buy the company report.
Charges & borrowings
Open charges
₹2.26 Cr
Satisfied charges
₹4.56 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Apr 2021 | 100463380 | Others | ₹25 Lakh | Open | |
| 10 Mar 2017 | 100101747 | Others | ₹1 Cr | Open | |
| 31 Dec 2016 | 100069981 | Others | ₹1.01 Cr | Open | |
| 25 Nov 2019 | 100374185 | Axis Bank Limited | ₹3.1 Cr | Satisfied | |
| 12 Feb 2015 | 10548678 | Andhra Pradesh State Financial Corporation | ₹1.46 Cr | Satisfied |
To see the full charge records of Clinsync Clinical Research Private Limited, buy the company report.
Total charge records: 5 View all charges
Legal cases
Clinsync Clinical Research Private Limited has 1 court case on record: 1 filed by Clinsync Clinical Research. All case is disposed.
Total cases
1
Filed by the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Rangareddy, Telangana | Civil suit | Filed by the company against Finosco Pharma Private Limited Rep by Its Director | Disposed |
To see the full case history of Clinsync Clinical Research Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Clinsync Clinical Research Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Clinsync Clinical Research has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
1
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| International Drug Discovery & Clinical Research Private Limited | U73100TG2009PTC065747 |
To see the full group structure of Clinsync Clinical Research Private Limited, buy the company report.
Employees & EPFO
Clinsync Clinical Research Private Limited has a workforce of 147 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
Employee count
147
Active EPFO establishments
1
Employee growth
0.68%
GST
Clinsync Clinical Research has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAECC3366N1ZB | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Clinsync Clinical Research Private Limited, buy the company report.
Recent activity
Clinsync Clinical Research Private Limited has 13 board changes on record since 2018: 4 appointments and 9 cessations. The latest: Suresh Kumar Nandiraju was appointed as Director on 26 Aug 2024.
AGM
Clinsync Clinical Research Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Appointed
Suresh Kumar Nandiraju was appointed as Director.
Filing
Clinsync Clinical Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Ceased
Rambabu Maddela ceased to be Director.
Charges
A charge with Others amounted to Rs. 0.25 Cr with Charge ID 100463380 was registered on 26 Apr 2021.
Charges
A charge registered on 25 Nov 2019 via Charge ID 100374185 with Axis Bank Limited was fully satisfied on 28 Jan 2021.
Appointed
Attili Venkata Satya Suresh was appointed as Director.
Appointed
Koteswara Prasad Sripathipanditaradhyula was appointed as Director.
Ceased
Attili Venkata Satya Suresh ceased to be Director.
Ceased
Suresh Kumar Nandiraju ceased to be Additional Director.
Charges
A charge with Axis Bank Limited amounted to Rs. 3.10 Cr with Charge ID 100374185 was registered on 25 Nov 2019.
Charges
A charge registered on 12 Feb 2015 via Charge ID 10548678 with Andhra Pradesh State Financial Corporation was fully satisfied on 16 Oct 2019.
11 earlier events are in the company report.
Frequently asked questions
Clinsync Clinical Research is an active private limited company based in Hyderabad, Telangana, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 21 March 2011 (15+ years old) and is registered under CIN U73200TG2011PTC073413.
Clinsync Clinical Research has 4 current directors:
- Sandhya Nandiraju - Whole-Time Director
- Suresh Kumar Nandiraju - Director
- Attili Venkata Satya Suresh - Director
- Koteswara Prasad Sripathipanditaradhyula - Director
The latest financial statements of Clinsync Clinical Research on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Clinsync Clinical Research is 36AAECC3366N1ZB, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Clinsync Clinical Research is U73200TG2011PTC073413. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Clinsync Clinical Research has 1 court case on record: 1 filed by the company.
Clinsync Clinical Research was incorporated on 21 March 2011, making it 15+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Clinsync Clinical Research by revenue are Finoso Pharma Private Limited, Semler Research Center Private Limited, Suven Life Sciences Limited, Sravathi Advance Process Technologies Private Limited, Eurofins Advinus Discovery Services Private Limited and 1 more, all in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development).
Suresh Kumar Nandiraju was appointed as Director on 26 Aug 2024. Rambabu Maddela ceased to be Director on 09 Oct 2023. Attili Venkata Satya Suresh was appointed as Director on 30 Nov 2020. Clinsync Clinical Research has 13 board changes on record in total.
Yes, Clinsync Clinical Research is registered as a small enterprise under Udyam registration (number: UDYAM-TS-02-0020478).
Clinsync Clinical Research can be reached through the website clinsynccro.com. Its registered office is in Hyderabad, Telangana, India.